The week in health tech, explained in plain English.Get the free newsletter →
September 29, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Providence to Fully Exit Insurance Business as MA Deal Fails

Providence plans to completely shut down Providence Health Plan after it could not reach a deal with a national insurer to operate its Medicare Advantage business, the health system told Becker's Hospital Review. "We are in discussion with regulators about this development and the broader wind-down of Providence's health plan operations," a spokesperson said, adding that more details would follow.

The move caps a difficult stretch for provider-owned insurance. Running a health plan requires scale, capital, and actuarial expertise that many hospital systems struggle to sustain, especially in Medicare Advantage. Rising medical costs, tighter federal payment and audit rules, and pressure on star ratings have squeezed margins across the program, prompting even large national insurers to trim MA offerings.

For Providence, exiting lets the system refocus on its core hospital and clinical operations. Members will need to find new coverage, and regulators will oversee an orderly wind-down. The decision signals that owning a payer is no longer a clear strategic win for many integrated systems.

More in Payers

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.

Payers

Payer AI Is Driving Up the Hidden RCM Tax on Providers

Payer AI is accelerating claim denials and underpayments, fueling a multi-billion dollar cost to providers that some call the RCM Tax.

Why it matters: As insurers automate claim denials, providers that fail to modernize their revenue cycle risk losing significant revenue to rework and unappealed claims.